Status:

RECRUITING

CONFIRM: Magnetic Resonance Guided Radiation Therapy

Lead Sponsor:

Brigham and Women's Hospital

Conditions:

Gastric Cancer

Invasive Breast Cancer

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This research is being done to determine the safety and feasibility of using a type of radiation guided by magnetic resonance imaging (MRI) and chemotherapy to treat patients with gastric and breast c...

Detailed Description

This is a master clinical protocol evaluating magnetic resonance (MR) image guided radiation in patients with gastric and breast cancer. In this research study, the investigators are researching if g...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Participants must have histologically or cytologically confirmed malignancy requiring radiation
  • Age 18 years of older
  • ECOG performance status ≤2 (Karnofsky ≥60%, see Appendix A)
  • Ability to understand and the willingness to sign a written informed consent document.
  • Any further criteria listed in the specific disease site cohort
  • Exclusion Criteria
  • History of allergic reactions attributed to gadolinium-based IV contrast
  • \-- Note: If patient will not receive contrast, this is not applicable and kidney function will not affect eligibility
  • Severe claustrophobia or anxiety
  • Participants who cannot undergo an MRI
  • Any other exclusion criteria listed in the specific disease site cohort

Exclusion

    Key Trial Info

    Start Date :

    May 1 2021

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    June 18 2029

    Estimated Enrollment :

    70 Patients enrolled

    Trial Details

    Trial ID

    NCT04368702

    Start Date

    May 1 2021

    End Date

    June 18 2029

    Last Update

    July 28 2025

    Active Locations (2)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (2 locations)

    1

    Brigham & Women's Hospital

    Boston, Massachusetts, United States, 02115

    2

    Dana Farber Cancer Institute

    Boston, Massachusetts, United States, 02115